Urinary f-Glucuronidase Activity in Cancer of the Bladder and Other Diseases
1960

Urinary Beta-Glucuronidase Activity in Bladder Cancer and Other Diseases

Sample size: 325 publication Evidence: moderate

Author Information

Author(s): F. J. W. Lewis, Constance H. J. Plaice

Primary Institution: Department of Pathology, Southmead Hospital, Bristol

Hypothesis

Increased urinary beta-glucuronidase activity may be associated with bladder cancer.

Conclusion

The study found that urinary beta-glucuronidase activity was significantly higher in patients with bladder cancer compared to normal subjects and other diseases.

Supporting Evidence

  • Patients with bladder cancer had significantly higher urinary beta-glucuronidase activity compared to healthy subjects.
  • Urinary enzyme activity was not significantly different in cancer patients compared to other diseases when adjusted for urine volume.
  • 86% of men and 52% of women had urinary beta-glucuronidase inhibitors present.

Takeaway

This study looked at a special enzyme in urine that might help doctors understand bladder cancer better. They found that people with bladder cancer often have more of this enzyme in their urine.

Methodology

The study involved collecting 24-hour urine samples from patients and analyzing the beta-glucuronidase activity using a modified method.

Potential Biases

There may be bias due to the selection of control groups and the influence of other diseases on enzyme activity.

Limitations

The study did not account for all potential confounding factors, such as variations in urine collection methods and the influence of medications.

Participant Demographics

The study included 32 healthy subjects, 87 patients with other genito-urinary diseases, 120 patients with miscellaneous diseases, and 86 bladder cancer patients, with a majority being male.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication